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ABSTRACT 
Nucleic acids are important bio-macromolecules in living systems. They are involved in 
important functions like gene expression and regulation. Nucleoside triphosphates serve as 
precursors for biochemical synthesis of modified nucleic acids and nucleotide coenzymes. The 
modification of nucleic acids, particularly at nucleobases, can expand the function and chemical 
properties of nucleic acid. Herein, we report the chemical synthesis of a novel thiol-modified 
nucleoside S-(3-(acetylthio)propyl)-5-(mercaptomethyl)-uridine and the corresponding 
nucleotide via a “new synthetic methodology” developed in our laboratory. The synthesized 
triphosphate was used for RNA transcription. The activity and nuclease resistance of the 
transcribed RNA is studied. The results showed that the properties of the nucleotide with thiol 
functionality are as good as the native.  The modified RNA can be used for RNA/protein 
complex structure studies and gold nanoparticles stabilizer. They can also serve as a probe in 
DNA/RNA microchip surface functionalization for detection of various diseases and pathogens. 
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1 
1 INTRODUCTION  
1.1 Nucleic acids 
Nucleic acids, which include deoxyribonucleic acids (DNA) and ribonucleic acid (RNA), 
are important bio-macromolecules with polymeric structure in living systems. They are essential 
for all known forms of life. Because of the specific structure of nucleic acids and their crucial 
role in genetic systems, fully understanding the chemistry of DNA and RNA constitutes a central 
element in our knowledge of any kind of life existing in the universe. The quest for such an 
understanding has been an initiation of many research areas in the nucleic acid field. For 
example, synthesis of chemically modified nucleic acid analogous and comparing them with the 
natural counterparts has been one of the most interesting strategy to investigate properties of 
nucleic acids.
2,3
 Nowadays, more and more attention has been put on the synthesis and 
modification of nucleic acid derivatives.
4-7
 Various modifications in nucleic acid structure have 
helped scientists to have an in-depth understanding about nucleic acid structures and functions.
8,9
 
Nucleoside triphosphates, which are the building block of nucleic acids, serve as direct 
precursors for chemical synthesis of modified unnatural nucleic acids and nucleotide 
coenzymes.
10,11
 Over the past few decades, nucleoside triphosphates (NTPs) and deoxy-
nucleoside triphosphates (dNTPs) are finding widespread application in biochemistry and 
molecular biology as substrates for DNA and RNA polymerases for sequencing, mutagenesis, 
and the labeling of hybridization probes and also therapeutics.
12-15
 The emergence of RNA/DNA 
technology and unusual properties of DNA/RNA molecules has drawn the attention of 
researchers in RNA chemistry, biochemistry and molecular biology.
16
 
2 
1.2 Thiol modified nucleosides and nucleotides 
Medicinal problems have been concern for all societies. Nano-science is one of the most 
progressing areas in today’s research; therefore, it should be beneficial for human health and 
curing disease. Metal nanoparticles started having therapeutic application in 1970s. Among all 
metals, gold nanoparticles (AuNPs) have been proved to be superior to classic compounds.
17
 
There are many methods to prepare and stabilize medically useful AuNPs. Various 
stabilizers can be utilized to keep high quality of AuNPs such as: citrate, various ligands, 
polymers, dendrimers, surfactants and also biomolecules such as oligonucleotides and DNA and 
RNA. Thiolates (for instance oligonucleotides modified with a thiolate group) have been proved 
to be the best stabilizer for AuNPs.
17-19
 This is based on the fact that thiol functionality has a 
strong tendency to form self-assembled monolayers in gold surface by being chemisorbed. DNA 
and RNA can immobilize AuNPs if they are modified by thiol functionalities. Thiols can 
stabilize AuNPs by forming a strong Au—S bond between the soft “Au” acid and the soft base 
“S”.20  
Herein, we report the synthesis of a novel thiol modified nucleoside and corresponding 
nucleotide and biochemical studies of the thiol-RNA/DNA. Our ultimate goal is to use this thiol-
functionalized triphosphate and DNA/RNA to stabilize AuNPs. Our hypothesis is that 
incorporating multiple thiol functionality into the oligonucleotide could increase the stability of 
the S—Au bond; therefore, more stabilized AuNPs. These stabilized AuNPs will be further used 
in DNA/RNA microchip surface functionalization for detection of various diseases and 
pathogens. Moreover, the thiol-oligonucleotide thus formed can also serve as a probe for 
RNA/protein complex structure and functions studies.  
3 
2     EXPERIMENTAL 
S-(3'-S-acetylpropyl)-5-(mercaptomethyl)-uridine was synthesized from 5-methyl uridine in 
seven steps. The purified nucleoside then was used to synthesize S-(3'-S-acetylpropyl)-5-
(mercaptomethyl)-uridine -5'-triphosphate. The triphosphate thus formed was used as a substrate 
for T7 RNA polymerases. The stability of the transcribed thiol-RNA was tested by treating with 
different nuclease enzyme to investigate its resistance. The activity of the hammerhead 
ribozyme, product of the transcription, was tested as well. The 2’-deoxy version of this 
nucleotide was synthesized previously by us using similar procedure and it is reported as a part 
of dissertation of our former lab member
1
. Herein, I am reporting again some of our result from 
2’-deoxy version for the comparison purposes. 
2.1 Materials and instrumentation  
Most solvents and reagents were purchased from Sigma-Aldrich, Fisher Scientific and 
Fluka and were used as obtained, unless otherwise specified. Solid reagents were dried under 
high vacuum. The reactions were performed under argon gas with stirring. All solvents were 
dried and purged with argon before use. Solvent mixtures are indicated as volume/volume ratios. 
Analytical thin layer chromatography (TLC, Dynamic Adsorbents, Inc.) was conducted using 
alumina basic TLC plates with F254 indicator (0.250 mm thick), and visualized under UV-light. 
Column chromatography was performed using Fluka silica gel (mesh size 0.040 – 0.063 mm). 
Transcription experiment was done using T7 RNA Polymerase and Transcription Kit from 
Epicenter Company. A DNA template (55 nt, 5’-TGTACGTTTCGGCCTTTCGGCCTCATCAG 
GTTGCCATAGTGAGTCGTATTACGC-3’) was designed and synthesized on solid phase for 
in vitro transcription of the thiol-modified hammerhead ribozymes using the NTPs analogues. T7 
RNA polymerase promoter (top strand DNA, 55-nt, 5’-GCGTAATACGACTCACT 
4 
ATAGGCAACCTGATGAGGCCGAAAGGCCGAAACGTACA-3’) and an RNA substrate (5’-
GGUCAUCUUUCCUAC-CUGUACGUCGUUGCCUAA-3’) for activity study were purchased 
from Integrated DNA Technologies. RNase R was bought form Epicenter. Phosphodiesterase I 
from Crotalus Adamanteus venom and Fetal Bovine Serum (FBS) were purchased from Sigma-
Aldrich and Life Technologies respectively. The DNA templates and primer used for enzymatic 
incorporation of the 2’-deoxy nucleotide was synthesized by solid phase synthesis. 
NMR spectra were recorded on Bruker-400 MHz. All chemical shifts (δ) are in ppm 
relative to tetramethylsilane (TMS). High-resolution mass spectra (HR-MS) and MALDI 
analyses were performed at Georgia State University Mass Spectrometry Facility, Atlanta, 
Georgia.  
 
2.2 Synthesis of the thiol-functionalized nucleoside 
S-(3’-S-acetylpropyl)-5-(mercaptomethyl)-uridine was synthesized from 5-methyl uridine 
in seven steps (Scheme 2.1). The 2’-deoxy version was also synthesized using similar 
methodology. Herein, the focus of synthesis report is on the ribo version of the nucleoside. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
 
 
Scheme  2.1 Synthesis of S-(3’-S-acetylpropyl)-5-(mercaptomethyl)-uridine, (7); The pink color 
shows the substituent atoms for the 2’-deoxy version of the nucleosides. 
 
 
2.2.1  2', 5'-Bis-O-(tert-butyldimethylsilyl)-5-methyluridine, 1 
5-methyl uridine (1 g, 0.0039 mol), tert-butyldimethylsilyl chloride (TBDMSi-Cl) (3.5 g, 
0.0192 mol, 6 eq) and imidazole (1.6 g, 0.0192 mol, 6 eq) were dissolved in anhydrous 
dimethylformamide (DMF) (10 mL). The reaction mixture was stirred for 12 h at room 
temperature. The reaction progress was monitored by recording TLC (5% ethyl acetate in 
dichloromethane; Rf = 0.4). When starting material was consumed completely, the reaction 
mixture was poured into ethyl acetate (150 mL) and extracted with saturated sodium bicarbonate 
6 
solution (8 X 50 mL). The organic phase was dried over anhydrous magnesium sulfate (MgSO4). 
The solvent was evaporated under reduced pressure. The pale yellow oily syrup was purified via 
silica gel flash column chromatography (2% methanol in dichloromethane) to give compound 1 
(3.2 g, 100% yield) as a colorless sticky liquid. HR-MS (ESI): chemical formula: C22H42N2O6Si2, 
Observed mass [M-H]
-
: 485.2499 (Calculated mass = 485.2509): Figure 3.1Error! Reference 
ource not found.; 
1
H NMR (CDCl3): Figure 3.2; 
13
C NMR (CDCl3): Figure 3.3 
2.2.2 2', 5'-Bis-O-(tert-butyldimethylsilyl)-5-bromomethyl-uridine, 2 
2', 5'-Bis-O-(tert-butyldimethylsilyl)-uridine, 1 (800 mg, 1.64 mmol), N-bromo-
succinimide (730 mg, 4.1 mmol, 2.5 eq.), and benzoyl peroxide (32 mg, 0.1312 mmol, 0.08 eq.) 
were dissolved in CCl4 (25 mL). The reaction was heated to reflux for 1 h, during this time the 
solution changed from colorless to orange. Completion of the reaction was monitor by TLC, 
using 8% ethyl acetate in dichloromethane as eluent (Rf = 0.6). The reaction was allowed to cool 
and filtered to remove insoluble succinimide. The solvent was evaporated in vacuo to yield a 
crude yellow 2', 5'-bis-O-(tert-butyldimethylsilyl)-5-bromomethyl-uridine, 2. The crude 
compound 2 was used as such, without further purification for the next step. 
2.2.3 S-acetyl-2', 5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)-uridine, 3 
Crude compound 2 and potassium thioacetate (AcSK) (470 mg, 4.1 mmol, 2.5 eq. of 
compound 1) were placed in a 50 mL flask and dried under vacuum for about 30 minutes. 
Anhydrous DMF (3 mL) was added to the reaction flask, under argon atmosphere. The reaction 
was heated at 70 °C for 1.5 h. The reaction mixture was diluted with ethyl acetate (90 mL) and 
washed with saturates NaHCO3 aqueous solution (5 X 30 mL).The organic phase was dried 
using anhydrous MgSO4.  The solvent was evaporated in vacuo to yield dark brown oily syrup of 
crude compound 3. The crude product 3 was purified using gradient column chromatography (0, 
7 
1, 2, 3% EtOAc in CH2Cl2) to yield a brown product. Rf = 0.4 in 8% ethylacetate in CH2Cl2; HR-
MS (Figure 3.4): Chemical formula: C24H44N2O7SSi2, Observed mass [M-H]
-
: 559.2339 
(Calculated mass = 559.2330), 
1
H NMR (CDCl3) (Figure 3.5) and 
13
C NMR (CDCl3) (Figure 
3.6). 
2.2.4 2', 5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)-uridine, 4 
Compound 3 was dissolved in MeOH (3 mL) and hydrolyzed using 1 M NaOH/MeOH 
solution (1 mL). Based on TLC (using 8% ethyl acetate in CH2Cl2, Rf = 0.2) the reaction 
completed in 4 h at room temperature. The reaction mixture was neutralized with AcOH and 
solvent was evaporated under reduced pressure to yield dark brown solid. The crude compound 4 
was used as such for the next step. 
2.2.5 S-(3-bromopropyl)-2',5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)-
uridine, 5 
Crude compound 4, K2CO3 (2 eq.) and DTT (1 eq.) were placed in a 50 mL flask and dried 
under vacuum for about 15 min. Anhydrous DMF (5 mL) was added to the reaction flask, under 
argon atmosphere. The reaction was stirred at room temperature for 1 h. Reaction progress was 
monitored by TLC (5 % EtOAc in CH2Cl2, Rf = 0.2). 1,3-Dibromopropane (10 eq.) was added 
drop wise to the reaction mixture, under argon atmosphere, with vigorous stirring. The reaction 
was stirred at room temperature for 12 h. The reaction mixture was diluted with ethyl acetate (60 
mL) and washed with saturated aqueous NaHCO3 solution (20 mL, five times).The organic 
phase was dried using anhydrous MgSO4.  The solvent was evaporated in a reduced pressure 
rotary evaporator to yield brown oily compound 5. The crude product 5 was purified using 
gradient column chromatography (0, 1, 2, 3% EtOAc in CH2Cl2) to yield a golden-brown oily 
product. Rf = 0.45 in 5% EtOAc in CH2Cl2; HR-MS (Figure 3.7): Chemical formula: 
8 
C25H47BrN2O6SSi2, Observed mass [M-H]
-
: 637.1819
 
(Calculated mass = 637.1877), 
1
H NMR 
(CDCl3) (Figure 3.8) and 
13
C NMR (CDCl3) (Figure 3.9). 
2.2.6  S-(3(acetylthio)propyl)-3',5'-bis-O-(tert-butyldimethylsilyl)-5-mercaptomethyl)-
uridine, 6 
Compound 5 and AcSK (2.5 eq.) were placed in a 50 mL flask and dried under vacuum 
for about 15 min. Anhydrous DMF (5 mL) was added to the reaction flask, under argon 
atmosphere. The reaction was heated at 70 °C for 1.5 h. The reaction mixture was diluted with 
ethyl acetate (60 mL) and washed with saturated NaHCO3 solution (5 X 20 mL).The organic 
phase was dried using MgSO4.  The solvent was evaporated in vacuo to yield brown oily 
compound 6. The crude product 6 was purified using gradient column chromatography (0, 1, 2, 3 
and 4% EtOAc in CH2Cl2) to yield a golden brown oily product. Rf = 0.5 in 8% ethylacetate in 
CH2Cl2; HR-MS (Figure 3.10): Chemical formula: C27H50N2O7S2Si2 Observed mass [M-H]
-
: 
633.2547 (Calculated mass = 633.2525); 
1
H NMR (CDCl3) (Figure 3.11) and 
13
C NMR (CDCl3) 
(Figure 3.12). 
2.2.7 S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine, 7 
Compound 6 (30 mg, 0.047 mmol) was dissolved in dry tetrahydrofuran (1 mL). 
Triethylamine-trihydrofluoride (20 μL, 0.47 mmol. 10 eq.) was added to the reaction flask, under 
argon atmosphere, while stirring. The reaction was heated at 45 °C for 12 h. Reaction progress 
was monitored by analytical TLC (eluent: 10% MeOH in CH2Cl2). The reaction mixture was 
neutralized by triethylamine. The solvent was evaporated under reduced pressure and the crude 
product 7 was purified using preparative TLC plate (10% MeOH in CH2Cl2, Rf = 0.5) to yield 7 
(2 mg, 10%) as a pale orange solid product. HR-MS (Figure 3.13): Chemical formula: 
9 
C15H22N2O7S2, Observed mass [M-H]
-
: 405.0787   (Calculated mass = 405.0868); 
1
H NMR 
(MeOD) (Figure 3.14) and 
13
C NMR (MeOD) (Figure 3.15). 
2.3 Synthesis of the thiol-functionalized nucleoside-5’ triphosphate 
2.3.1 S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridin-5’ triphosphate, 9 
S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine ([compound 7, Scheme 2.1],10 mg, 
0.015 mmol) was weighed in a 10 mL round bottom flask and dried overnight under vacuum. 2-
chloro-4H-1,3,2-benzodioxaphosphorin-4-one (5 mg, 1.5 eq.) was dried in another flask for 5 
minutes. Tributylammonium pyrophosphate (25 mg, 3 eq.) was dried overnight in a separate 
flask, under high vacuum. The 2-chloro-4H-1,3,2-benzodioxa-phosphorin-4-one was dissolved in  
dry DMF (0.1 mL) . The pyrophosphate was also dissolved in dry DMF (0.3 mL) with additional 
tributylamine (TBA) (0.1 mL) and transferred by a syringe into the flask containing the 2-chloro-
4H-1,3,2-benzodioxa-phosphorin-4-one under argon atmosphere. A lot of argon was purged 
through the reaction flask as the mixture was allowed to react at room temperature. The mixture 
was allowed to stir at room temperature for 45 minutes to yield an inorganic triphosphate. During 
that time, the vacuum dried compound 7 was dissolve in dry DMF (0.3 mL) and an additional of 
dry toluene (0.1 mL). The prepared triphosphate solution was added to the flask containing 
compound 7.  The combined contents were allowed to stir at room temperature for 2.5 h to yield 
the cyclic phosphite intermediate 8 (Scheme 2.2). Reaction was monitored at this step by TLC 
(10% MeOH in CH2Cl2; Rf = 0.35). The cyclic-phosphite 8 was then oxidized by adding iodine 
solution (0.1% I2/THF/Pyridine/H2O, 0.4 mL). The mixture was stirred for 40 min and then 
hydrolyzed with water (3 mL) and allowed to stir at room temperature for 12 h to ensure 
complete hydrolysis. The sample was precipitated using NaCl (0.3 M)/ ethanol (3 volumes). The 
precipitate was analyzed using analytical TLC (5:3:2 of iso-PrOH:30% NH3.H2O:H2O; Rf = 0.3). 
10 
The crude S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine-5'-triphosphate was desalted by a 
syringe filter to be prepared for HPLC purification. The sample was then purified and analyzed 
by reversed-phase high performance liquid chromatography (RP-HPLC). 5% yield; HR-MS 
(Figure 3.16): Chemical formula:  C15H25N2O16P3S2, Observed mass [M-H]
-
: 644.9756 
(Calculated mass = 644.9786); 
1
H NMR (D2O) (Figure 3.17); 
13
C NMR (D2O) (Figure 3.18); 
31
P 
NMR (D2O) (Figure 3.19). 
2.3.2 S-mercaptopropyl-5-(mercaptomethyl)-uridin-5’ triphosphate, 10 
The pure triphosphate 9 was treated with ammonia in 5% ammonium hydroxide in 
methanol/water 1:1 (v/v) solution at room temperature and overnight to remove acetyl group 
from the thiol functionality in the side chain. Then ammonia was evaporated in vacuu-fuge. The 
pH of the sample was checked to make sure it is neutral. Then, it was precipitated in NaCl (0.3 
M)/ ethanol (3 volumes). HR-MS (Figure 3.20): Chemical formula:  C15H25N2O16P3S2, Observed 
mass [M-H]
-
: 644.9756 (Calculated mass = 644.9786); 
1
H NMR (D2O) (Figure 3.21); 
13
C NMR 
(D2O) (Figure 3.22); 
31
P NMR (D2O) (Figure 3.23). 
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Scheme  2.2 Synthesis of S-mercaptopropyl-5-(mercaptomethyl)-uridine-5'-triphosphate (The 
pink color indicates the 2’-deoxy version) 
 
2.4 RP-HPLC Analysis and Purification 
The crude compound 9 (AcSUTP) was purified and analyzed by reverse-phase high-
performance liquid chromatography (RP-HPLC). The purification was performed on a 
Welchrom C18-XB (10 μm, 21.1 × 250 mm) preparative column, using Shimadzu SPD-10A VP 
liquid chromatography by monitoring under 260 nm, with a flow-rate of 6 mL/min [buffer A: 10 
mM triethylammoniumacetate (TEA.Ac, pH 7.1) in water; buffer B: 10 mM TEA.Ac (pH 7.1) in 
50% acetonitrile in water] and a linear gradient starting from 5% buffer B to 40% buffer B in 10 
min, reaching 100% buffer B in 20 min and in 30 min going back to 5% buffer B. The desired 
peak was collected and the buffer was removed by lyophilization. All the dry fractions of 
compound 9 were analyzed on Welchrom C18-XB column (4.6 × 250 mm, 5 μ) and measured at 
12 
a flow rate of 1.0 mL/min and a linear gradient of 0 to 25% buffer B in 20 min, reaching to 100% 
buffer B in 22 min, staying at 100% buffer B for 5 minutes, then going back to 0% buffer B till 
the end of program, which was totally 36 min [buffer A: 20 mM TEA.Ac (pH 7.3) in water; 
buffer B: 20 mM TEA.Ac (pH 7.3) in 50% acetonitrile]. A RP-HPLC profile of crude compound 
9 is shown in Figure 3.24. And RP-HPLC analysis of purified compound 9, at 260 nm 
wavelength, is presented in Figure 3.25. The white precipitates of compound 10 (HSUTP) were 
also analyzed by analytical RP-HPLC at 260 nm with a flow rate of 1.0 mL/min and a linear 
gradient of 0 to 25 % buffer B in 20 min (Figure 3.25). 
2.5 UV-VIS property study 
UV-VIS spectra were obtained by a reference to deionized water (Figures 3.27 and 3.28). 
The base line was subtracted from the recorded spectra all the time.  
2.6 Synthesis of oligonucleotides 
The DNA primer (P) and template (T) sequences (Table 3.1) were synthesized by solid 
phase synthesis on an automated Applied BioSystem 394 DNA Synthesizer (Applied 
Biosystems, Foster City, CA) using standard β-cyanoethylphosphoramidite chemistry (1 μmol 
scale).
1
 Oligonucleotides were synthesized in DMTr-off mode, with average coupling efficiency 
more than 99%. The oligonucleotides were de-protected in concentrated NH4OH (55 °C, 16 h), 
and purified by 19% denaturing polyacrylamide gel electrophoresis. The gel was visualized 
under UV light. The desired band was cut off and transferred into a tube, crushed and soaked in 
water overnight.  Water was removed by lyophilization and the residue of the gel was soaked 
again in order to maximize the extraction of oligonucleotide from the gel. The oligonucleotides 
were dissolved in less amount of water and then recovered from water solution by NaCl (0.3 M)/ 
13 
ethanol (3 volumes) precipitation. Oligonucleotides were quantified by UV-Vis absorbance at 
260 nm using standard molar extinction coefficients and characterized by MALDI-TOF MS.
1
 
2.7 Enzymatic studies 
2.7.1 RNA transcription 
Transcription experiment was performed by following the standard procedures from the 
manufacturer, Epicentre (AmpliScribe T7- Flash Transcription Kit).
21
 The materials for the 
transcription experiments were labeled using radioactive ATP Alpha 
32
P (Perkin Elmer, Boston, 
MA). Each transcription reaction (5 μL) contained ATP, CTP, GTP, and UTP or HSUTP or 
AcSUTP (0.5 mM each), linearized plasmid DNA template (1 μM) (T55: 5′-TGT ACG TTT 
CGG CCT TTC GGC CTC ATC AGG TTG CCT ATA GTG AGT CGT ATT ACG C-3’), the 
complementary 55-nt promoter, DTT (10 mM), transcription buffer (1×) for T7 RNA 
polymerase, T7 RNA polymerase (1 unit/μl), and RNase-free water. In order to minimize 
pipetting error, all the materials except the T7 RNA polymerase enzyme and uridine 
triohosphates (UTP, HSUTP and AcSUTP) were mixed together in a cocktail solution, then 
divided into three portions to be used for the three different substrates. The T7 RNA polymerase 
enzyme was added the last to each reaction vial.  In the time-course experiments, a gel-loading 
dye (10 μl) saturated with urea and containing 100 mM EDTA was used to quench the reaction at 
each time point, then the reaction mixture was stored in dry ice until the end of experiment. It 
was followed by loading 5 μl of the reaction mixture containing dye on a 19% denaturing 
polyacrylamide gel electrophoresis and then autoradiography (Figure 3.29). The transcription 
experiment was further performed using three more different templates (Figure 3.30): 
T G4 :    5’- TGT GCG TTT CGG CCT TTC GGC CTC ATC AGG TTG CCT ATA GTG AGT 
CGT ATT ACG C-3’ 
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T G28  :  5’- TGT ACG TTT CGG CCT TTC GGC CTC GTC AGG TTG CCT ATA GTG AGT 
CGT ATT ACG C-3’ 
T G32  : 5’- TGT ACG TTT CGG CCT TTC GGC CTC ATC GGG TTG CCT ATA GTG AGT 
CGT ATT ACG C-3’ 
2.7.2 Ribozyme activity study 
Transcription of the hammerhead ribozyme (5′-GGCAACCUGAUGAGGCCGAAAGG 
CCGAAACGUACA-3’) for the catalytic activity experiments was carried out using the standard 
procedures described previously (150 μL reaction scale). For this transcription experiment, the 
55-nt double stranded DNA  (5′-TGTACGTTTCGGCCTTTCGGCCTCATCAGGTTGCCTAT 
AGTGAGTCGTATTACGC-3′) and its complementary sequence was used. After the 
transcription, the native and thiol-modified ribozymes were precipitated in NaCl (0.3 M)/ ethanol 
(3 volumes) and adjusted to the same concentration, monitored by UV-VIS and using standard 
extinction coefficient for oligonucleotides. The RNA substrate (20 nt, 5′-ACCUGUACGUCG 
UUGCCUAA-3′; Integrated DNA Technology (IDT), Coralville, IA) was kinased with γ-32P-
ATP at the 5′ end for the ribozyme digestion by one hour incubating the RNA with T4 
polynucleotide kinase (Thermo Fisher Scientific, Waltham, MA) and 1x reaction buffer for T4 
PNK at 37 °C , followed by NaCl (0.3 M)/ ethanol (3 volumes) precipitation. The digestion was 
completed in the buffer (10 mM Tris-HCl, 10 mM MgCl2, pH 7.6) and with 5′-
32
P-labeled RNA 
substrate (final concentration: 50 μM) at room temperature.  Aliquots (5 μL each) were taken at 
the time intervals (0, 5, 10, 30, 60, and 120 min), and each was diluted with 10 μL gel loading 
dye containing EDTA (50 mM) and saturated urea solution (aqueous), followed by storing in dry 
ice to quench the digestion. The 5′-radio labeled RNA substrate was cleaved into the 9-nt 
fragment and the 5′-32P-RNA fragment (11-nt). Digestion of the 32P-labled RNA substrate was 
15 
monitored via denaturing 19% polyacrylamide gel electrophoresis and autoradiography.  The 
time-course results of the ribozyme digestion are shown in Figure 3.31.  
2.7.3 Ribozyme durability study 
The procedure of durability study was the same as that of ribozyme activity study 
mentioned above. However, the concentration of the transcribed ribozyme was diluted to 1:10 of 
that in activity study. Moreover, the time intervals were as: 0, 2, 4, 6, 24 and 72 h. The 19% 
denaturing polyacrylamide gel electrophoresis of this study was then visualized by 
autoradiography (Figure 3.32).  
2.7.4 Nuclease resistance experiment 
The ribozymes were transcribed as previously discussed. The transcribed ribozymes were 
purified by centrifugation using a membrane (3000 Dalton cutoff). The concentrated samples 
were adjusted to the same molar concentration, analyzed by UV-VIS. These modified and native 
ribozymes were then digested with fetal bovine serum (FBS), RNase R and phosphodiesterase I 
from Crotalus Adamanteus venom. The digestion time was set for 30 min, 1 and 2 h at 37°C. In 
order to find the best resistance of the synthesized ribozymes, different concentration of the 
nuclease enzymes were used. The reaction was quenched by adding 7 μL of gel loading dye 
containing EDTA (100mM), saturated with urea. The digestion reactions were analyzed by 19% 
PAGE and autoradiography (Figures 3.33, 3.34, 3.35 and 3.36).  
2.7.5 DNA polymerization of the 2’-deoxy version nucleotide1 
The 5’-end of the DNA primers were radio-labeled using γ-[32P]-ATP (Perkin Elmer, 
Boston, MA) and T4 polynucleotide kinase (New England Biolabs, Beverly, MA) and incubating 
16 
at 37 °C for one hour. The kinase reaction was quenched by heating up the reaction mixture to 70 
°C for five minutes, followed by NaCl (0.3 M)/ ethanol (3 volumes) precipitation.  
DNA primer(s) (P1 or P2, Table 3.1) and DNA template(s) (T1, T2 or T3, Table 3.1), 
dNTPs (dATP, dCTP and dGTP, Epicentre Biotechnologies, Madison, WI), dNTP substrate 
(TTP/ AcSTTP/ HSTTP) and DTT were premixed together in Klenow exo-minus DNA 
polymerase 10x reaction buffer. Klenow exo-minus DNA polymerase (Epicentre 
Biotechnologies, Madison, WI) was added to the prepared cocktail solution and incubated at 37 
°C for the desired time.  The reaction mixtures were quenched by adding the gel loading dye 
solution (10 μL each, containing 50 % glycerol, 0.60 % xylene cyanol, 0.60 % bromophenol 
blue, 20 mL of 1 mM EDTA, saturated urea) and analyzed on 19%, polyacrylamide gel 
electrophoresis (PAGE). For single nucleotide enzymatic incorporation reactions, no other 
dNTPs, except the T substrate (TTP/ AcSTTP/ HSTTP), were added to the reaction mixture. The 
reaction mixtures were incubated at 37 °C for desired time. Analysis was done on a 19%, 
polyacrylamide gel electrophoresis. Polymerase reactions contained primer (1.5 μM), template (3 
μM), dNTPs (0.1 mM each), DTT (5 mM), and 10X reaction buffer (1X) in a final reaction 
volume of 5 μL. 
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3     RESULTS AND DISCUSSION 
3.1 Synthetic route design and characterization of the synthesized compounds 
As shown in Scheme 2.1, both S-(3’-S-acetylpropyl)-5-(mercaptomethyl)-uridine and S-
(3’-S-acetylpropyl)-5-(mercaptomethyl)-2'-deoxyuridine were synthesized similarly from 5-
methyluridine and thymidine, respectively, in seven steps. Compounds 1, 2 and 3 were 
synthesized based on literature reported methodology.
15
 The nucleoside 5’-triphosphates were 
synthesized using new methodology developed in our lab
22
 (Scheme 2.2) and then characterized 
successfully.  
The free 2'- and 5'- hydroxyl groups on 5-methyluridine, as well as the 3’ and 5’ –OH 
groups on thymidine were protected with tert-butyldimethylsilyl protecting group. The reaction 
was quite clean and efficient yielding nearly 100% of pure 2', 5'-bis-O-(tert-butyldimethylsilyl)-
5-methyluridine and 3', 5'-bis-O-(tert-butyldimethylsilyl)-thymidine.  Formation of compound 1 
was confirmed by high resolution mass spectrometry (Figure 3.1), and the purity of the 
compound was analyzed by 
1
H (Figure 3.2) and 
13
C NMR (Figure 3.3). 
 
 
 
 
 
 
 
 
Figure  3.1 ESI-MS analysis of 2', 5'-Bis-O-(tert-butyldimethylsilyl)-uridine, 1, Chemical 
formula: C22H42N2O6Si2, Observed mass [M-H]
-
: 485.2499 (Calculated mass = 485.2509) 
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Figure  3.2 1H NMR of 2', 5'-bis-O-(tert -butyldimethylsilyl)-5-methyluridine, 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.3 13C NMR of 2', 5'-bis-O-(tert -butyldimethylsilyl)-5-methyuridine, 1. 
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3', 5'-bis-O-(tert-butyldimethylsilyl)-5- bromomethyl-uridine (2) was yielded by using N-
bromosuccinimide to afford radical bromination at benzylic position under reflux conditions, in 
the presence of catalytic amounts of benzoyl peroxide. Using filtration, residual insoluble 
succinimide was then removed. Compound 2 was used instantly without any purification. Since 
this compound was difficult to purify, any characterization of it was difficult. 
Nucleophilic substitution of bromide in compound 2 was accomplished by using  
thioacetate to obtain S-acetyl-2', 5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)-uridine 
(compound 3). The molecular formation of compound 3 was confirmed by ESI-MS (high 
resolution) analysis (Figure 3.4). The purity of compound 3 was confirmed by NMR analysis 
(Figures 3.5 and 3.6). 
 
 
  
Figure  3.4 ESI-MS analysis of S-acetyl-2',5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)-
uridine, 3 
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, Chemical formula: C24H44N2O7SSi2. Observed mass [M-H]
-
:  559.2339 
(Calculated mass = 559.2330) 
 
20 
  
Figure  3.6 1H NMR of S-acetyl-2', 5'-bis-O-(tert-butyldimethylsilyl)-5-(mercaptomethyl)-
uridine, 3. 
Figure  3.5 13C NMR of S-acetyl-3', 5'-bis-O-(tert-butyldimethylsilyl)-5-
(mercaptomethyl)-2'-deoxyuridine, 3. 
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Compound 4 was afforded by alkaline hydrolysis of compound 3 using sodium hydroxide 
in methanol. Due to strong tendency of un-protected S-H group on compound 4 to form a dimer 
by making disulfide bond, any characterization or purification of it was difficult. Therefore, the 
sample was used as such for the next step. 
The disulfide bind thus formed resulting from dimerization of compound 4 was reduced 
in situ with dithiothreitol (DTT). The reaction was done in an argon rich, oxygen free 
atmosphere. The free thiol anion [ –S]-  thus generated, was alkylated using 1,3-dibromopropane 
to afford compound 5. Compound 5 is a stable intermediate and was purified by column 
chromatography and characterized by NMR (Figures 3.8 and 3.9).  The molecular formation of 
compound 5 was confirmed by ESI-MS (high resolution) analysis (Figure 3.7). 
  
Figure  3.7 ESI-MS analysis of S-(3’-bromopropyl)-2', 5'-bis-O-(tert-butyldimethylsilyl)-5-
(mercaptomethyl)-uridine, 5, Chemical formula: C25H47BrN2O6SSi2 , Observed mass [M-
H]
-
:  637.1819  (Calculated mass = 637.1877). 
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Figure  3.8 1H NMR of S-(3’-bromopropyl)-2', 5'-bis-O-(tert-butyldimethylsilyl)-5-
(mercaptomethyl)-uridine, 5 
Figure  3.9 13C NMR of S-(3’-bromopropyl)-2', 5'-bis-O-(tert-butyldimethylsilyl)-5-
(mercaptomethyl)-uridine, 5 
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Nucleophilic substitution of bromide in compound 5 by thioacetate yielded compound 6. 
The molecular formation of compound 6 was confirmed by ESI-MS (high resolution) analysis 
(Figure 3.10). The purity of compound 6 was analyzed by NMR (Figures 3.11 and 3.12). 
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Figure  3.11 1H NMR of S-(3(acetylthio)propyl)-2', 5'-bis-O-(tert-butyldimethylsilyl)-
5-(mercaptomethyl)-uridine, 6 
Figure  3.10 ESI-MS analysis of S-(3(acetylthio)propyl)-2', 5'-bis-O-(tert-
butyldimethylsilyl)-5-(mercaptomethyl)-uridine, 6, Chemical formula : C27H50N2O7S2Si2,  
Observed mass [M-H]
-
:  633.2547  (Calculated mass = 633.2525). 
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De-protection of compound 6 using TEA.3HF and HF was initially challenging, and we 
had difficulty removing TBDMS group from 2’ and 5’ position of the ribo-nucleoside. To 
overcome this problem, we tried another protecting group (triisopropylsilyl (TIPS) ethers) to 
protect simultaneously 3’ and 5’ of 5-methyluridine at the first step. However the reaction didn’t 
work after step two. Therefore, we decided to use TBDMS again, but remove it from compound 
5 first and then introduce thioacetate to it to obtain compound 7. This strategy was also 
challenging: having two triol compound to purify by column was time consuming and not very 
efficient. Other than using TEA.3HF and HF to remove TBDMS, we used another fluoride 
reagent and solvent system for de-protection. Pyridine.HF complex (70%) and EtOH was 
employed for 3', 5'-bis-O-desilylation reaction. The reaction was successful. However, the yield 
Figure  3.12 13C NMR of S-(3(acetylthio)propyl)-2', 5'-bis-O-(tert-butyldimethylsilyl)-5-
(mercaptomethyl)-uridine, 6 
25 
was not great. At the end, we were able to remove protecting groups using triethylamine 
trihydrofluoride (TEA.3HF) in vary dry THF and obtain a higher yield. The molecular formation 
of compound 7 was confirmed by ESI-MS (high resolution) analysis (Figure 3.13) and then 
characterized by NMR (Figures 3.14 and 3.15). 
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Figure  3.13 ESI-MS analysis of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine, 7  
Figure  3.14 1H NMR of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine,7 
Chemical formula: C15H22N2O7S2, Observed mass [M-H]
-
:  405.0787 (Calculated mass = 
405.0796). 
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S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine-5'-triphosphate (AcSUTP, compound 
9, Scheme 2.2) was synthesized from S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine 
(compound 7 in Scheme 2.1) using a relatively new methodology
22
 developed in our lab.  Our 
earlier attempts to synthesize the 5’-triphosphate of the deoxy-nucleoside version by using DMF 
or DMF/1,4-dioxane (1:1) mixture as the solvent systems was not successful. Only after 
dissolving the nucleoside in DMF/toluene (3:1) mixture, formation of triphosphate was observed. 
Our hypothesis is that toluene can interact with the bulky base, providing better stacking and 
therefore, causing the 5’ hydroxyl group more available to afford cyclic phosphate intermediate 
(compound 8, Scheme 2.2). This strategy was used for the ribo version as well. In order to obtain 
better yield and cleaner reaction, several optimization such as changing reaction time and the 
Figure  3.15 13CNMR of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine,7 
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equivalent of the reagents were tried. The best yield was observed when reaction time between 
nucleoside and triphosphate was 2 h (second step in Scheme 2.2) and the equivalent of 
tributylammonium pyrophosphate and 2-chloro-4H-1,3,2-benzodioxa-phosphorin-4-on  to the 
nucleoside was 3 and 1.5 respectively. Compound 9 was characterized using HR-MS and 
1
H, 
13
C 
and 
31
P NMR analysis as shown in Figures 3.16 to 3.19. 
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Figure  3.17 ESI-MS analysis of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine-5’-
triphpsphate, 9, Chemical formula: C15H25N2O16P3S2, Observed mass [M-H]
-
: 644.9756 
(Calculated mass = 644.9786). 
Figure  3.16 1H NMR analysis of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-
uridine-5’-triphpsphate, 9. 
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AcSUTP 
Figure  3.18 13C NMR analysis of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-
uridine-5’-triphpsphate, 9. 
AcSUTP 
Figure  3.19  31P NMR analysis of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-uridine-5’-
triphpsphate, 9. 
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The acetate protecting group of the thiol functionality of compound 9 was removed in 
presence of ammonia, yielding S-mercaptopropyl-5-(mercaptomethyl)-uridine-5'-triphosphate 
(HSUTP, Compound 10, Scheme 2.2). Figures 3.20 to 3.23 represent HR-MS and NMR analysis 
of compound 10. 
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Figure  3.20 ESI-MS analysis of S-mercaptopropyl-5-(mercaptomethyl)-uridine-5’-
triphpsphate 10, Chemical formula: C13H22N2O15P3S2, Observed mass [M-H]
-
: 602.9653 
(Calculated mass = 602.9680). 
HSUTP 
Figure  3.21 1H NMR of S-mercptopropyl-5-(mercaptomethyl)-uridine-5’-triphosphate,10 
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HSUTP 
Figure  3.22 13C NMR of S-mercptopropyl-5-(mercaptomethyl)-uridine-5’-triphosphate,10 
HSUTP 
Figure  3.23 31P NMR of S-mercptopropyl-5-(mercaptomethyl)-uridine-5’-triphosphate,10 
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3.2 RP-HPLC purification and analysis 
The crude compound 9 (AcSUTP) was purified and analyzed by reverse-phase high-
performance liquid chromatography (RP-HPLC). Several HPLC programs were tried to get the 
best resolution. Only the program shown in Figure 3.24 afforded the best separation. Compound 
9 (AcSUTP) eluted at 20.20 min under this condition. Compound 10 was purified by only 
NaCl/EtOH precipitation and then analyzed on RP-HPLC at flow rate of 1.0 mL/min under 260 
nm. The HPLC profile of the crude compound 9 is shown in Figure 3.22. The desired peak had 
retention time of 20.20 min and it was stronger than other peaks, meaning the synthesis has been 
efficient and clean. All native uridine 5’-triphosphate and the purified thiol modified ones were 
analyzed on RP-HPLC (Figure 3.25). Since AcSUTP and HSUTP are structurally similar, the 
difference on their retention time on the column was small but measurable. The retention time 
difference was much smaller in the deoxy version. RP-HPLC analysis of the deoxy version is 
showed in Figure 3.26.  
 
 
Figure  3.24 RP-HPLC profile of crude compound 9, and the program used, (retention 
time of the desired peak: 20.20 min) 
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Figure  3.25 RP-HPLC analysis of UTP, AcSUTP and HSUTP  
HS
TTP 
AcS
TTP 
Figure  3.26 RP-HPLC analysis of AcSTTP and HSTTP1 HSTTP (red curve, retention 
time: 24.75 min); AcSTTP (blue curve, retention time: 24.96 min) and co-injection of 
AcSTTP and HSTTP (black curve, retention times: 24.75 and 24.96 min, respectively). 
UTP: orange curve, retention time: 11.48 min; AcSUTP: blue curve, retention time: 
24.86 min; HSUTP: green curve, retention time: 23.25; Co-injection of all: violet curve, 
retention times: 11.48, 23.25 and 24.86 
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3.3 UV-VIS absorption properties 
The maximum UV absorption of the native uridine 5’-tripohosphate was measure at ~262 
nm. The modified uridine 5’-triphosphate (AcSUTP & HSUTP) showed maximum absorption at 
~267 nm, which is slightly different from that of the native UTP. The UV absorption profiles of 
AcSUTP and AcSUTP were similar (Figure 3.27). Unlike uridine, modification at the nucleobase 
of thymidine did not change the wavelength of the maximum absorption of the native TTP at all. 
All TTP, S-(3(acetylthio)propyl)-5-(mercaptomethyl)-2'-deoxyuridine-5'- triphosphate (AcSTTP) 
and S-mercaptopropyl-5-(mercaptomethyl)-2'-deoxyuridine-5'- triphosphate, (HSTTP)  have 
similar UV absorption profiles (Figure 3.28). 
 
 
Figure  3.27 UV absorption spectra of UTP (—), AcSUTP (—), and HSUTP (—) in water at 
room temperature. 
  
34 
 
Figure  3.28 UV absorption spectra of TTP (—), AcSTTP (—), and HSTTP (—) in water at room 
temprature.
1
 
 
3.4  Enzymatic studies 
3.4.1 RNA in vitro transcription by T7 RNA polymerase 
Transcription of the RNA for the native and the thiol-modified nucleotides were 
performed using T7 RNA polymerase and by following the manufacturer procedure (Epicentre, 
AmpliScribe T7- Flash Transcription Kit). A 55-mer DNA template and the complementary 
promoter for the T7 RNA polymerase were used in presence of all NTPs and radioactive α-[32P]-
ATP. The transcribed RNA’s were analyzed on a 19% PAGE. Autoradiogram of the time-course 
experiment of the transcription is shown in Figure 3.29. From the intensity of the bands, it can be 
determined that the modified nucleotides are recognizable by T7 RNA polymerase and can act as 
good substrates for the T7 enzyme. It was observed that transcription of AcSUTP substrate is 
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initially faster but the yield is lower than that of native. The transcription yield of HSUTP seems 
even better than the native UTP. Incorporation of the HSUTP & AcSUTP into RNA will be 
further confirmed by MALDI-MS.  
 
 Figure  3.29 Transcription time course experiment.  
and the poduct of the reaction in presence of T7 RNA polymerase. b) Gel autoradiogram of 
the reaction (analyzed on 19% PAGE). c) Normalized curves, quantified by phosphoroimager, 
intensities were measure by reference to the intensity of UTP in 120 min as 100%. 
 
a) Sequences of promoter and template used 
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Transcription was also carried out using three other templates shown in Figure 3.30. 
These templates were designed in such a way that the ribozyme thus produced will have C 
instead of U in two positions.  Therefore, in each sequence of these templates, one A has been 
replaced by G. The reaction time was 2 h, and 19% PAGE was used for analysis. The results 
showed that the modified nucleotides (AcSUTP & HSUTP) gave better yield compared to the 
native UTP.  
 
Figure  3.30 Transcription experiment using mutant templates; a) sequences of promoter and 
templates used; b) sequences of the ribozymes thus produced; c) gel autoradiogram of the 
experiment. 
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3.4.2 Ribozyme catalytic activity analysis 
The activity of the transcribed hammerhead ribozyme was examined by incubating the 
5’-32P labeled 20-nt substrate with the transcribed RNAs in presence of Tris-HCl/MgCl2 buffer. 
The gel image (Figure 3.31) shows that the 5′-radio labeled RNA substrate was cleaved into the 
9-nt fragment and the 5′-32P-RNA fragment (11-nt), suggesting that the thiol-modified ribozymes 
are as active as the native counterpart.  
 
Figure  3.31 Catalytic activity of the modified ribozyme and the native counterpart.  
 
 
 
 
  
a) Secondary structure of the transcribed hammerhead ribozyme and its labeled 
substrate. The red letters indicated that the bases are highly conserved. b) 
Normalized curves of the modified ribozymes activity (red and green curves) by 
comparison to the cleavage of the substrate by the native U-ribozyme (120 min was 
defined as 1). c) time-course experiment of the digestion of the labeled substrate at 
5’-end by hammerhead native and modified ribozymes. 
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3.4.3 Ribozyme durability study 
To examine the durability of the transcribed ribozyme, they were 10 fold diluted with 
respect to the concentrations  in the activity study and were incubated with 5’-32p-labeled RNA 
substrate at room temperature for longer time. The time intervals were 0, 2, 4, 6, 24 and 72 h. 
The autoradiograph of this experiment (Figure 3.32) indicates that the AcSU-modified ribozymes 
is as durable as the native one. However, HSU-ribozyme did not show durability like the native 
one. 
 
Figure  3.32 Gel autoradiogram of the ribozyme durability study 
 
3.4.4 Nuclease resistance experiment 
The stability of the transcribed ribozymes was examined by incubating the transcribed 
RNAs with different nucleases including Fetal Bovine Serum (FBS), phosphodiesterase (PDE) I 
from Crotalus Adamanteus venom and RNase R (various amounts and different reaction times) 
and analyzed on 19% gel electrophoresis and autoradiography (Figures 3.33, 3.34, 3.35 and 
3.36). 
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Figure  3.33 PAGE autoradiography of nuclease resistance experiment.  
 
 
 
 
 
 
 
 
Figure  3.34 PAGE autoradiography of nuclease resistance experiment. 
 
a) Digestion of Native U-RNA, b) digestion of HSU-RNA, c) digestion of AcSU-RNA, 
enzyme concentration used: 0.1 U/μL of RNase R, 0.04% of Fetal Bovine Serum (FBS) 
and 10
-5
 U/μL of phosphodiesterase (PDE), reaction mixtures were incubated at 37 °C for 
30 min. 
 
 
a) Digestion of Native U-RNA, b) digestion of HSU-RNA, c) digestion of AcSU-RNA, 
enzyme concentration used: 0.05 U/μL of RNase R, 0.02% of Fetal Bovine Serum (FBS) 
and 10
-5
 U/μL of phosphodiesterase (PDE), reaction mixtures were incubated at 37 °C for 
30 min. 
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Figure  3.35 PAGE autoradiography of nuclease resistance experiment.  
 
 
 
 
Figure  3.36 PAGE autoradiography of nuclease resistance experiment.  
 
 
 
The result shows that the modified RNAs are relatively resistant to the nucleases and 
their stability is similar to the native. 
a) Digestion of Native U-RNA, b) digestion of HSU-RNA, c) digestion of AcSU-RNA, 
enzyme concentration used: 0.1 U/μL of RNase R, 0.006% of Fetal Bovine Serum (FBS) 
and 0.3x10
-5
 U/μL of phosphodiesterase (PDE), reaction mixtures were incubated at 37 
°C for 30 min. 
 
a) Digestion of Native U-RNA, b) digestion of HSU-RNA, c) digestion of AcSU-RNA, 
enzyme concentration used: 0, 0.1, 0.01, 0.001 U/μL of RNase R. Reaction mixtures were 
incubated at 37 °C for 1h. 
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3.4.5 Incorporation of 2’-deoxy version of nucleotides into DNA1 
The incorporation efficiency of S-(3(acetylthio)propyl)-5-(mercaptomethyl)-2'-
deoxyuridine-5'-triphosphate (AcSTTP, 9) and S-mercaptopropyl-5-(mercaptomethyl)-2'-
deoxyuridine-5'-triphosphate, (HSTTP, 10) into DNA was investigated by using different 
combination of DNA templates and primers (listed in Table 3.1) under Klenow exo-minus DNA 
polymerase (Kf-). 
 
Table  3.1 Sequences of the DNA primers and templates used for enzymatic incorporation of 
TTP/HSTTP/AcSTTP into DNA. The highlighted bases are where incorporation of “T” occurs. 
 
 The DNA polymerization was carried out with primer (1.5 μM), template (3 μM), all 
NTPs including TTP/AcSTTP/ HSTTP (0.1 mM each), and Klenow exo(-) DNA polymerase 
(various concentrations) and analyzed by 19% polyacrylamide gel electrophoresis (Figures 3.37, 
3.39 and 3.40).  
The results showed that AcSTTP and HSTTP act as good substrates for DNA 
polymerase, like TTP. A relatively short DNA template (T1, 21-nt) was used to study single 
nucleotide incorporation. As can be seen in Figure 3.37, AcSTTP is a better substrate for DNA 
polymerase: in different conditions (various enzyme concentration and reaction time), AcSTTP 
terminates DNA polymerization once single nucleotide incorporates into DNA (n+1 DNA), 
Primers: P1 (17-mer) 5'-d-TAG CGG GTT GCT GGT GG -3' 
 P2 (21-mer) 5'-d-GCG TAA TAC GAC TCA CTA TAG-3' 
Templates: T1 (21-mer) 3'-d-ATC GCC CAA CGA CCA CCA TGG- 5' 
 T2 (23-mer) 3'-d-ATC GCC CAA CGA CCA CCAAAT GG- 5' 
 
T3 (55-mer) 3'-d-CGC ATT ATG CTG AGT GAT ATC CGT TGG ACT ACT 
CCG GCT TTC CGG CTT TGC ATG T -5' 
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while TTP and HSTTP cause formation of either n+1 DNA or a mixture of n+1 and n+2 DNA. 
In addition, the intensity of the products on the gel autoradiogram indicates that DNA 
polymerase can recognize both HSTTP and AcSTTP well. Moreover, it appears that there is a 
measurable difference in the mobility of the products as a result of structural impact that 
modification causes. The single nucleotide incorporation of HSTTP is confirmed by MALDI-MS 
analysis (Figure 3.38). AcSTTP single nucleotide incorporation will be confirmed by MALDI-
MS as well. 
 
Figure  3.37 Single nucleotide enzymatic incorporation of TTP/AcSTTP/HSTTP into DNA (T1):   
 
 
(a) incorporation of TTP/AcSTTP/HSTTP by Klenow exo(-) into DNA template T1. PAGE 
autoradiography of the polymerization reaction with (b) Kf(-) = 0.0015 U/µL and reaction time 
= 60 min for TTP and 90 min for AcSTTP and HSTTP, (c) Kf(-) = 0.00075 U/µL and  
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reaction time = 60 min, (d) Kf(-) = 0.0015 U/µL and reaction time = 30 min, and (d) Kf(-) = 
0.00075 U/µL and reaction time = 30 min. 
 
 
Figure  3.38 MALDI-TOF MS analysis of the single nucleotide incorporation of HSTTP into 
DNA by Kf(-).Chemical Formula: C181H229N68O111P17S2, matrix: 3-hydroxypicolinicacid 
(3HPA); Observed mass: 5722.6 (Cal. mass: 5720.9)  
 
In order to examine the incorporation efficiency of three consecutive modified thymidine 
5’-triphosphates, template T2 was used. Primer P1 (17-nt) was extended to a 20-nt DNA using 
Kf(-) and by incorporation of three consecutive “T” bases on template T2. The DNA 
polymerization reaction was carried out in the presence of (1.5 μM), template (3 μM), TTP/ 
AcSTTP/ HSTTP (0.1 mM), and Klenow exo(-) DNA polymerase (0.0015 U/µL) and then was 
analyzed on a 19% PAGE (Figure 3.39). The incubation time for TTP was 5 min (Figure3.39, 
lane 2) while AcSTTP and HSTTP were incubated for 60 min (Figure3.39, lanes 3 and 4, 
respectively). In these conditions, AcSTTP seems to be the best substrate for DNA polymerase. 
44 
We also designed a longer DNA template (55-nt, T3) to further investigate the 
incorporation efficiency. The polymerization reaction was performed on extension of primer P2 
(21-nt) over template T3 (55-nt). The reaction was carried out using primer (1.5 μM), template (5 
μM), all dNTPs including TTP/ AcSTTP/TTP (0.1 mM), and Klenow exo(-) DNA polymerase 
(0.04 U/μL) followed by analyzing on a 19% PAGE. The results are shown in Figure 3.40. Three 
“T” were involved in this reaction 
 
 
Figure  3.39 Enzymatic incorporation of three consecutive thymidine bases 
(TTP/AcSTTP/HSTTP) into DNA (template T2):   
(a) Polymerization reaction of TTP, AcSTTP and HSTTP by Klenow exo(-) over DNA template 
T2. (b) Gel electrophoresis autoradiography of the incorporation reaction with Kf(-)= 0.0015 
U/µL, incubation time = 5 min for TTP (lane 2) and 60 min for HSTTP (lane 3) and AcSTTP 
(lane 4).  
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Figure  3.40 a) DNA polymerization reaction in presence of all dNTPs including TTP, AcSTTP 
and HSTTP using template T3 and  Klenow exo(-) b) Gel electrophoresis autoradiography of the 
experiment with Kf(-) = 0.0015 U/µL, incubation time = 60 min for TTP (lane 3) and 90 min  
HSTTP (lane 4) and AcSTTP (lane 5).  
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4 CONCLUSIONS AND FUTURE PROSPECTS 
We have successfully synthesized and characterized a novel nucleoside, S-(3’-S-
acetylpropyl)-5-(mercaptomethyl)-uridine, from 5-methyl uridine. The purified nucleoside was 
used to synthesize S-(3’-S-acetylpropyl)-5-(mercaptomethyl)-uridine -5'-triphosphate and S-
mercaptopropyl-5-(mercaptomethyl)-uridine -5'-triphosphate.  Both triphosphates were 
characterized successfully. The triphosphates thus formed were used as a substrate for T7 RNA 
polymerase. A 55-nt dsDNA templates and promoter were used to incorporate the modified 
triphosphate into RNA. The experiments showed that the modified ribozymes transcribed are as 
active as the native counterpart and this modification at the nucleobase will not cause any 
deficiency in the catalytic activity of the ribozymes. Like the native RNA, the modified ones are 
relatively resistant to the nucleases. The 2’-deoxy version of the same nucleoside and nucleotide 
were also synthesized and characterized. It was observed that the 2’-doxy thiol-modified 
nucleotide can act as an efficient substrate for DNA polymerase. The modified RNA/DNA thus 
obtained will be used for gold nanoparticle stabilization. Since Au-nanoparticles have strong 
affinity for thiol-functionality, the study will be based on that. The modified RNA/DNA will also 
find use and application in DNA/RNA microchip surface functionalization for rapid detection of 
disease and pathogens and also, it will be utilized in studying nucleic acid/protein complexes 
structure and function. 
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APPENDICES  
Appendix A: ESI HR-Mass spectra 
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Appendix B: 
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APENDIX D: 
31
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